# The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)

> **NCT00755794** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 800 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast sodium

## Key facts

- **NCT ID:** NCT00755794
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755794, "The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00755794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*